Retrovirus infections among patients treated in Britain with various clotting factors

Cheinsong-Popov, R.; Tedder, R.S.; O'Connor, T.; Clayden, S.; Smith, A.; Craske, J.; Weiss, R.
July 1986
British Medical Journal (Clinical Research Edition);7/19/1986, Vol. 293 Issue 6540, p168
Academic Journal
Examines the retrovirus infections among patients treated with clotting factors in Great Britain. Prevalence of viral infections in patients at risk for AIDS; Identification of the human T lymphotropic virus (HTLV) type; Failure of the HTLV to transmit blood products.


Related Articles

  • Antibodies to Human T-Lymphotropic Virus Type III and Development of the Acquired Immunodeficiency Syndrome in Homosexual Men Presenting with Immune Thrombocytopenia. Abrams, Donald I.; Kiprov, Dobri D.; Goedert, James J.; Sarngadharan, M.G.; Gallo, Robert C.; Volberding, Paul A. // Annals of Internal Medicine;Jan86, Vol. 104 Issue 1, p47 

    Presents information on a study which examined seropositivity for antibodies to the causative retrovirus and the progression in patients of isolated thrombocytopenia to overt AIDS. Methods; Results; Discussion.

  • Exacerbated signs of an immunosuppressive AIDS-like disease in macaques infected with multiple retroviruses. Mitchell, Jane L.; Hood, Simon; Auda, Ghazi; Almond, Neil M.; Rose, Nicola J. // Retrovirology;Jan2011 Supplement 1, Vol. 8, pA207 

    An abstract of the research paper titled,"Exacerbated signs of an immunosuppressive AIDS-like disease in macaques infected with multiple retroviruses," is presented.

  • Updated HIV Treatment Recommendations for 2002.  // American Family Physician;12/1/2002, Vol. 66 Issue 11, p2159 

    Discusses the study 'Antiretroviral treatment for adult HIV infection in 2002. Updated recommendations of the International AIDS Society-USA Panel,' by P.G. Yeni et al., from the July 10, 2002 issue of the 'Journal of American Medical Association.'

  • The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif. Sheehy, Ann M.; Gaddis, Nathan C.; Malim, Michael H. // Nature Medicine;Nov2003, Vol. 9 Issue 11, p1404 

    The human protein apolipoprotein B mRNA-editing enzyme-catalytic polypeptide-like-3G (APOBEC3G), also known as CEM-15, mediates a newly described form of innate resistance to retroviral infection by catalyzing the deamination of deoxycytidine to deoxyuridine in viral cDNA replication...

  • Weight Gain, Improvement in Metabolic Profile, and CD4 Count with Insulin Administration in an AIDS Patient. Kabadi, Udaya M. // AIDS Patient Care & STDs;Nov2000, Vol. 14 Issue 11, p575 

    Assesses the effect of subcutaneous (S.C.) insulin administration in conjunction with antiretroviral drug therapy in a subject with AIDS. Limited success of anabolic agents utilized for retarding or preventing progressive wasting of patients; Marked improvements in patients treated with S.C....

  • Body Habitus Alterations in HIV-Infected Women Treated with Combined Antiretroviral Therapy. Ridolfo, Anna Lisa; Gervasoni, Cristina; Bini, Teresa; Galli, Massimo // AIDS Patient Care & STDs;Nov2000, Vol. 14 Issue 11, p595 

    Fat distribution alterations are among the most frequent and unexpected side effects of combined antiretroviral therapy. They may occur in patients receiving protease inhibitor-containing regimens and those treated with combinations of only nucleoside reverse transcriptase inhibitors. The broad...

  • A mixed report card.  // Advocate;03/16/99, Issue 781, p13 

    Reports on the holding of the 1999 Conference on Retrovirus and Opportunistic Infections in Chicago, Illinois. Growing rate of drug failure among patients; Viral strains' growing resistant to drugs; Strong potential of several drugs.

  • Antiretroviral therapy is only part of it. Mbewu, Anthony // Bulletin of the World Health Organization;2001, Vol. 79 Issue 12, p1152 

    Focuses on the use of antiretroviral therapy in the prevention of AIDS in the developing countries. Efficacy of retroviral therapy in improving the quality of life; Diagnosis and selection of patients for treatment; Comparison between highly active antiretroviral therapy and directly observed...

  • HIV/AIDS 2001: Latest treatment strategies. Brown, Billy Ray; Robinson, Marvin // Drug Topics;3/19/2001, Vol. 145 Issue 6, p39 

    Presents updates on the development of treatment strategies for AIDS/HIV in 2001. Classes of antiretrovirals approved by the United States Food and Drug Administration; Study which determined the role of adherence to virologic failures in the majority of patients; Lipid management in HIV.

  • Porous metal—organic-framework nanoscale carriers as a potential platform for drug delivery and imaging. Horcajada, Patricia; Chalati, Tamim; Serre, Christian; Gillet, Brigitte; Sebrie, Catherine; Baati, Tarek; Eubank, Jarrod F.; Heurtaux, Daniela; Clayette, Pascal; Kreuz, Christine; Chang, Jong-San; Hwang, Young Kyu; Marsaud, Veronique; Bories, Phuong-Nhi; Cynober, Luc; Gil, Sophie; Férey, Gérard; Couvreur, Patrick; Gref, Ruxandra // Nature Materials;Feb2010, Vol. 9 Issue 2, p172 

    In the domain of health, one important challenge is the efficient delivery of drugs in the body using non-toxic nanocarriers. Most of the existing carrier materials show poor drug loading (usually less than 5 wt% of the transported drug versus the carrier material) and/or rapid release of the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics